<DOC>
	<DOC>NCT01476215</DOC>
	<brief_summary>This proof of principle PK study will allow GSKCH to select the most favorable sustained release formulation among 3 prototypes to move to the next stage of drug development.</brief_summary>
	<brief_title>A Pharmacokinetic Study Investigating the Rate and Extent of Paracetamol Absorption of Three Experimental Sustained Release Pediatric Suspensions</brief_title>
	<detailed_description />
	<mesh_term>Acetaminophen</mesh_term>
	<criteria>Healthy volunteer Body Mass Index between 19.0 28.0 (kg/m2) inclusive</criteria>
	<gender>Male</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>June 2014</verification_date>
	<keyword>paracetamol</keyword>
</DOC>